Search

Author/Creator Fedyanin, M

1. 119P Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma. (15th December 2019)

Authors:
Tjulandin, S; Fedyanin, M; Demidov, L; Moiseyenko, V; Protsenko, S; Odintsova, S; Semiglazova, T Y; Zukov, R; Lazarev, S; Andreev, A; Nechaeva, M; Makarova, J; Fadeeva, N; Tarasova, A; Kozlova, O; Shustova, M; Garipov, A; Ivanov, R
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 503PPrognostic factors of chemo-radiotherapy efficacy in patients with locally-advanced rectal cancer. (23rd October 2018)

Authors:
Fedyanin, M; Tryakin, A; Pokataev, I; Bulanov, A; Sekhina, O; Chekini, D; Gordeev, S; Aliev, V; Kuzmichev, D; Mamedli, Z; Barsukov, Y; Glebovskaya, V; Tkachev, S; Chernykh, M; Kozlov, N; Tjulandin, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 542PDroplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer. (23rd October 2018)

Authors:
Van Cutsem, E; Lesniewski-Kmak, K; Saunders, M P; Wasan, H; Argiles, G; Borg, C; Creemers, G-J M; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C J A; Stroyakovskiy, D; Ten Tije, A J; van de Wouw, A; Cattan, V; Desachy, G; Amellal, N; Moiseyenko, V M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. O-022Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis. (20th June 2018)

Authors:
Lesniewski-Kmak, K; Moiseenko, V; Saunders, M; Wasan, H; Argiles, G; Borg, C; Creemers, G; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C; Stroyakovskiy, D; Ten Tije, A; Van de Wouw, A; Kanehisa, A; Fougeray, R; Busto, N Lopez; Amellal, N; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. O-022Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis. (20th June 2018)

Authors:
Lesniewski-Kmak, K; Moiseenko, V; Saunders, M; Wasan, H; Argiles, G; Borg, C; Creemers, G; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C; Stroyakovskiy, D; Ten Tije, A; Van de Wouw, A; Kanehisa, A; Fougeray, R; Busto, N Lopez; Amellal, N; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P-058Trifluridine/tipiracil safety and efficacy in Russian patients with metastatic colorectal cancer and refractory or intolerant to standard chemotherapies: Results of the primary analysis. (2nd July 2019)

Authors:
Fedyanin, M; Chekini, D; Chubenko, V; Tjulandin, S; Zhabina, A; Amellal, N; Aubel, P; Gandossi, E; Moiseenko, V
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P-130Factors associated with the efficacy of aflibercept in patients with metastatic colorectal cancer: results of the multicenter observational study. (2nd July 2019)

Authors:
Fedyanin, M; Chubenko, V; Belonogov, A; Beluhin, S; Belyaeva, A; Bolotina, L; Vladimirova, L; Zhabina, A; Zagorskaya, L; Khalikova, L; Fakhrudinova, O; Moiseenko, F; Khasanova, A; Musaeva, H; Novikova, O; Stradaeva, I; Mukhametshina, G; Orlova, R; Micshenko, A; Popova, I
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018)

Authors:
Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018)

Authors:
Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗